Detalhe da pesquisa
1.
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.
N Engl J Med;
383(10): 919-930, 2020 09 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32877582
2.
Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment.
Muscle Nerve;
67(2): 124-129, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36504406
3.
Gut- and oral-dysbiosis differentially impact spinal- and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset.
BMC Neurol;
22(1): 62, 2022 Feb 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35189854
4.
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis.
Muscle Nerve;
63(1): 31-39, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33063909
5.
Randomized Trial of Thymectomy in Myasthenia Gravis.
N Engl J Med;
375(6): 511-22, 2016 08 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27509100
6.
Primary progressive aphasia and amyotrophic lateral sclerosis (PPA-ALS): A longitudinal case study.
Appl Neuropsychol Adult;
: 1-4, 2024 Jan 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38241787
7.
Oral Edaravone - Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis.
Expert Rev Neurother;
23(10): 859-866, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37646130
8.
MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial.
Amyotroph Lateral Scler Frontotemporal Degener;
24(3-4): 304-310, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36503310
9.
Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS.
J Med Econ;
26(1): 488-493, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36930042
10.
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success.
Amyotroph Lateral Scler Frontotemporal Degener;
24(5-6): 523-534, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37254449
11.
Role of disease severity, illness perceptions, and mood on quality of life in muscle disease.
Muscle Nerve;
46(3): 351-9, 2012 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22907225
12.
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine.
Muscle Nerve;
53(2): 165-8, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26662952
13.
Validation of the individualised neuromuscular quality of life for the USA with comparison of the impact of muscle disease on those living in USA versus UK.
Health Qual Life Outcomes;
9: 114, 2011 Dec 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22177525
14.
Vibratory asymmetry in mobile vocal folds: is it predictive of vocal fold paresis?
Ann Otol Rhinol Laryngol;
120(4): 239-42, 2011 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21585153
15.
Futures Planning at the AAN: Approach and Initial Outcome.
Neurology;
96(22): 1032-1040, 2021 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35833271
16.
Use of a new ALS specific respiratory questionnaire: the ARES score.
Amyotroph Lateral Scler Frontotemporal Degener;
22(sup1): 48-53, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34348538
17.
Pulmonary function decline in amyotrophic lateral sclerosis.
Amyotroph Lateral Scler Frontotemporal Degener;
22(sup1): 54-61, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34348540
18.
Whole-genome analysis of sporadic amyotrophic lateral sclerosis.
N Engl J Med;
357(8): 775-88, 2007 Aug 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17671248
19.
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.
Ann Neurol;
66(2): 235-44, 2009 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19743457
20.
Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis.
Amyotroph Lateral Scler Frontotemporal Degener;
21(7-8): 509-518, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32573277